NCT05789069
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05789069
Title A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors HiFiBiO Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
New Experimental Therapeutics of Virginia - NEXT Oncology Fairfax Virginia 22031 United States Details
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli 80131 Italy Details
UOC Fase I - Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore Rome 00168 Italy Details
Centro Ricerche Cliniche di Verona s.r.l. Verona 37134 Italy Details
Clinica Universidad de Navarra - Madrid Madrid 28027 Spain Details
South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz Madrid 28040 Spain Details
South Texas Accelerated Research Therapeutics (START) Madrid - CIOCC Madrid 28050 Spain Details
Clinica Universidad de Navarra - Pamplona Pamplona 31008 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field